A. De Monte

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients.

M. Velussi, A. Cernigoi, A. De Monte, 1997, Journal of hepatology.

Liberal bilateral internal thoracic artery use in people with diabetes neutralizes the negative impact of insulin-requiring status

G. Sinagra, A. Pappalardo, G. Gatti, 2017, Journal of cardiovascular medicine.

Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.

S. Bonin, G. Stanta, L. Cattin, 2018, Molecular and clinical oncology.

Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention

G. Barbati, G. Sinagra, M. Merlo, 2013, Journal of cardiovascular medicine.

Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.

G. Crepaldi, F. Lirussi, G. Zanette, 2002, Diabetes, nutrition & metabolism.